Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Parkinson’s disease: where do westand?
    Patrick J. Sweeney, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 269-270;

    Although a cure has not been found, certain drugs can relieve symptoms and may actually slow disease progression.

  • You have access
    The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: insights and highlights from the chairman
    Alan Bakst, PharmD and Ray W. Gifford, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 273-277;

    Highlights include the new classification schema and recommendations on the use of labetalol.

  • You have access
    Hemopericardium and cardiac tamponade associated with warfarin therapy
    Kamthorn S. Lee, MD and Thomas Marwick, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 336-338;
  • You have access
    Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation
    Albert G. Hakaim, MD, MSc and Caldwell B. Esselstyn, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 331-335;

    BACKGROUND Parathyroid carcinoma is rare, with a reported prevalence of 0.6% to 4.0% in patients presumed to have primary hyperparathyroidism. This study examines the long-term results of surgical therapy and combination chemotherapy.

    PATIENTS From 1938 to 1988, 1260 operations for primary hyperparathyroidism were performed; only six patients (0.47%) were subsequently found to have parathyroid carcinoma. A seventh patient was referred to our institution after the diagnosis of parathyroid carcinoma had been made.

    RESULTS All patients had excessive hypercalcemia (serum calcium concentration > 12.0 mg/dL) with a range of 12.3 to 18.3 mg/dL. Locally recurrent tumors causing recurrent hypercalcemia were managed by repeated neck exploration and tumor resection. Six of the seven patients (85%) survived 5 years, while four patients (57%) survived 10 years.

    CONCLUSIONS Diagnosis of parathyroid carcinoma rests upon postoperative surveillance of patients who have undergone previous neck exploration and resection of apparently benign adenomas. Long-term survival is possible with repeated resection of locally recurrent tumors.

  • You have access
    Assessing hypertension management: the role of 24-hour blood pressure monitoring
    Beatriz Esayag-Tendler, MD and William B. White, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 278-283;

    BACKGROUND The first fully automatic portable invasive blood pressure recorder was developed 30 years ago. Today, portable noninvasive ambulatory blood pressure devices are capable of measuring blood pressure intermittently for periods of 24 to 48 hours.

    OBJECTIVE To discuss the utility of automatic ambulatory blood pressure recording in assessing antihypertensive therapy.

    SUMMARY Ambulatory blood pressure monitoring is helpful in assessing the pharmacodynamics and the clinical efficacy of an-tihypertensive drugs. It is superior to office blood pressure measurement in predicting hypertensive end-organ disease. In clinical trials, ambulatory blood pressure monitoring permits a more varied population to enter a study, the number of subjects required is often reduced, and a placebo control group may be unnecessary.

    CONCLUSIONS The various methods of analyzing ambulatory blood pressure data should be used in a complementary fashion to evaluate antihypertensive drug therapy. We believe that this technique will soon become much more commonly used for hypertension management.

  • You have access
    Irritable bowel syndrome: new perspectives on management
    Marvin M. Schuster, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 270-272;

    Long classified as psychosomatic, irritable bowel syndrome is now considered a motor disorder in which a number of factors are at play.

  • You have access
    Hemodialysis-induced hypotension: the search for a cause
    Fetnat M. Fouad, MD
    Cleveland Clinic Journal of Medicine May 1993, 60 (3) 192-193;
  • You have access
    A medical approach to nicotine addiction treatment
    Thomas L. Petty, MD and Louise M. Nett, RN, RRT
    Cleveland Clinic Journal of Medicine May 1993, 60 (3) 254-258;
  • You have access
    ‘Education of those who serve’
    Herbert P. Wiedemann, MD
    Cleveland Clinic Journal of Medicine May 1993, 60 (3) 180;
  • You have access
    New feature: IM board review self-test
    Cleveland Clinic Journal of Medicine May 1993, 60 (3) 187;

Pages

  • Previous
  • Next
  • 1
  • …
  • 482
  • 483
  • 484
  • 485
  • 486
  • 487
  • 488
  • 489
  • 490
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire